A clinical study evaluated the performance of Bausch + Lomb's enVista Aspire intraocular lenses.
Bausch + Lomb announced results from a clinical study assessing its enVista Aspire intraocular lenses. The study examined the lenses' impact on vision outcomes.
Further details about the study design or participant results were not immediately available.
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →
